Display options
Share it on

Can Urol Assoc J. 2016 Mar-Apr;10(3):90-4. doi: 10.5489/cuaj.3456.

Enumerating pelvic recurrence following radical cystectomy for bladder cancer: A Canadian multi-institutional study.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Libni J Eapen, Edward Jones, Wassim Kassouf, Carole Lambert, Scott C Morgan, Madeleine Moussa, Robert Nam, Matthew Parliament, Laurie Russell, Fred Saad, D Robert Siemens, Luis Souhami, Ewa Szumacher, Scott Tyldesley, Yan Xu, Ingrid Zbieranowski, Rodney H Breau, Eric Belanger, Peter Black, Eric Estey, Julie Bowan, Bishwajit Bora, Michael Brundage, Peter Chung, Neil Fleshner, Andrew Evans, Glenn Bauman, Jonathan Izawa, Chris Davidson, Fadi Brimo

Affiliations

  1. The Ottawa Hospital Cancer Centre, University of Ottawa, Ottawa, ON, Canada;
  2. BC Cancer Agency, BC, Canada;
  3. McGill University Health Centre, Montreal, QC, Canada;
  4. Notre-Dame Hospital, Montreal, QC, Canada;
  5. Queen's University, Kinston, ON, Canada;
  6. Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada;
  7. Cross Cancer Institute, Edmonton, AB, Canada;
  8. Université de Montréal, Montreal, QC, Canada;
  9. Sudbury Cancer Centre, Sudbury, ON, Canada;
  10. Kingston Cancer Centre, Kingston, ON, Canada;
  11. Princess Margaret Hospital, Toronto, ON, Canada;
  12. London Cancer Centre, London, ON, Canada.

PMID: 27217852 PMCID: PMC4840007 DOI: 10.5489/cuaj.3456

Abstract

INTRODUCTION: We aimed to enumerate the rate of pelvic recurrence following radical cystectomy at university-affiliated hospitals in Canada.

METHODS: Canadian, university-affiliated hospitals were invited to participate. They were asked to identify the first 10 consecutive patients undergoing radical cystectomy starting January 1, 2005, who had urothelial carcinoma stages pT3/T4 N0-2 M0. The first 10 consecutive cases starting January 1, 2005 who met these criteria were the patients submitted by that institution with information regarding tumour stage, age, number of nodes removed, and last known clinical status in regard to recurrence and patterns of failure.

RESULTS: Of the 111 patients, 80% had pT3 and 20% pT4 disease, with 62% being node-negative, 14% pN1, and 27% pN2; 57% had 10 or more nodes removed. Cumulative incidence of pelvic relapse was 40% among the entire group.

CONCLUSIONS: This review demonstrates a high rate of pelvic tumour recurrence following radical cystectomy for pT3/T4 urothelial cancer.

References

  1. Cancer. 2014 Nov 15;120(22):3584 - PubMed
  2. Eur Urol. 2011 Jun;59(6):1009-18 - PubMed
  3. J Urol. 2011 Oct;186(4):1261-8 - PubMed
  4. N Engl J Med. 2003 Aug 28;349(9):859-66 - PubMed
  5. J Clin Oncol. 2001 Feb 1;19(3):666-75 - PubMed
  6. Can Urol Assoc J. 2009 Dec;3(6 Suppl 4):S237-42 - PubMed
  7. J Clin Oncol. 2004 Jul 15;22(14):2781-9 - PubMed
  8. Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):1032-7 - PubMed
  9. J Urol. 2002 Mar;167(3):1295-8 - PubMed
  10. Cancer. 2014 Apr 15;120(8):1272-80 - PubMed
  11. Eur Urol. 2012 Feb;61(2):243-4 - PubMed
  12. J Urol. 1962 Jun;87:853-68 - PubMed
  13. J Clin Oncol. 2011 Jun 1;29(16):2171-7 - PubMed

Publication Types